Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details) - Schedule of Common Share Equivalents and Potentially Dilutive Securities

v3.24.1
Summary of Significant Accounting Policies (Details) - Schedule of Common Share Equivalents and Potentially Dilutive Securities - shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted common shares outstanding 2,036,470,250 1,618,980,671
Stock options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted common shares outstanding 8,445,698 8,445,698
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted common shares outstanding 34,000,000 34,000,000
Series B preferred stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted common shares outstanding 335,772,090 164,635,079
Series C preferred stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted common shares outstanding 438,151,351 432,250,000
Convertible debt [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted common shares outstanding 1,220,101,111 962,679,774
Non-vested, forfeitable common shares [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted common shares outstanding 16,970,120